Quick answers
- What is Dibucaine used for?
- The Drug Facts label of CVS Topical Anesthetic Hemorrhoidal (Cvs Pharmacy, Inc) lists these uses: temporarily relieves pain and itching due to hemorrhoids or other anorectal disorders.
- Do I need a prescription for Dibucaine?
- No. The products on this page are sold without a prescription (over the counter).
- Is a store brand the same as the name brand?
- Products listed together below have the same active ingredient, in the same amount and the same form, as registered with the FDA. Inactive ingredients (such as colors, flavors and fillers) and package sizes can differ. Compare the “Active ingredient” box on both packages, and ask a pharmacist if you are not sure.
- Has Dibucaine been recalled?
- FDA enforcement reports list 2 recalls of products on this page; the newest started February 17, 2023. A recall usually concerns specific products or lots, not every brand.
Drug Facts label
Every over-the-counter medicine must carry a “Drug Facts” box in the same order, set by FDA rules. Below is the label of one product for each common strength and form, quoted word for word. Your own package can differ (for example, children’s products have other directions): always follow the label on your package.
CVS Topical Anesthetic Hemorrhoidal · Cvs Pharmacy, Inc
Dibucaine 1%, ointment (topical)
Active ingredient
Dibucaine 1% Purpose Local Anesthetic
Purpose
Local Anesthetic
Uses
temporarily relieves pain and itching due to hemorrhoids or other anorectal disorders
Warnings
For external use only Allergy alert
- certain persons can develop allergic reactions to ingredients in this product. If the symptoms being treated do not subside or if redness, irritation, swelling, pain or other symptoms develop or increase, discontinue use and ask a doctor.
Do not use
in or near the eyes in children under 2 years of age
When using this product
do not use more than directed unless directed by a doctor do not put this product into the rectum by using fingers or any mechanical device or applicator
Stop use and ask a doctor if
bleeding occurs condition worsens or does not improve within 7 days
If pregnant or breast-feeding
ask a health care professional before use.
Keep out of reach of children
If swallowed, get medical help or contact a poison control center right away.
Directions
adults and children 12 years and over: if possible, clean the affected area with mild soap and warm water and rinse thoroughly. Dry by patting or blotting with toilet tissue or a soft cloth before applying. apply externally to the affected area up to 3 or 4 times daily. children under 12 years of age: ask a doctor.
Inactive ingredients
Lanolin, Light Mineral Oil, Purified Water, White Petrolatum
— FDA label of CVS Topical Anesthetic Hemorrhoidal, Cvs Pharmacy, Inc, effective July 25, 2026. See the official label on DailyMed →
Dibucaine · Akron Pharma Inc.
Dibucaine 0.28 g/28 g, ointment (topical)
Active ingredient
Drug Facts Active ingredient Purpose Dibucaine 1% Hemorrhoidal ointment
Purpose
Uses temporanly relieves pain and nching due to hemorrhoids or other anorectal disorders
Uses
Do not use in children under 2 years at age in or near the eyes
Warnings
Warninigs For External Use Only Allergy alert certain persons can develop allergic reactions to ingredients in this product. If the symptoms being treated does not subside or redness, irritation, swelling, bleeding or other symptoms develop or increase, discontinue use and ask a doctor.
When using this product
avoid contact wnh eyes do not use more than directed unless directed by a doctor do not put this product into the rectum by using fingers or any mechanical device or applicator lf pregnant or breast feeding , ask a health care professional before use.
Keep out of reach of children
If swallowed, get medical help or contact a Poison Control Center right away.
Stop use and ask a doctor if
bleeding occurs condition worsens or does not improve wnhin 7 days
Directions
adults and children 12 years and over: if possible, clean the affected area with mild soap and wann water and nnse thoroughly. Dry by patting or blotting withh toilet tissue or a soft cloth before applying. apply externally to the affected area up to 3 or 4 times daily children under 12 years of age: ask a doctor
Inactive ingredients
Lanolin, Light Mineral Oil, Purified water, White Petrotalum
Questions?
call toll-free 1(877)225-6999 Manufactured for Akron Pharma, Inc., Fairfeld, NJ - 07004
— FDA label of Dibucaine, Akron Pharma Inc., effective January 12, 2025. See the official label on DailyMed →
CVS Topical Analgesic Hemorrhoidal · Cvs Pharmacy, Inc
Dibucaine 10 mg/mL, ointment (topical)
Active ingredient
Dibucaine 1% Purpose Local Anesthetic
Purpose
Local Anesthetic
Uses
temporarily relieves pain and itching due to hemorrhoids or other anorectal disorders
Warnings
For external use only. Allergy alert
- certain persons can develop allergic reactions to ingredients in this product. If the symptoms being treated do not subside or if redness, irritation, swelling, pain or other symptoms develop or increase, discontinue use and ask a doctor.
Do not use
in or near the eyes in children under 2 years of age
When using this product
do not use more than directed unless directed by a doctor do not put this product into the rectum by using fingers or any mechanical device or applicator
Stop use and ask a doctor if
bleeding occurs condition worsens or does not improve within 7 days
If pregnant or breast-feeding
ask a health care professional before use.
Keep out of reach of children
If swallowed, get medical help or contact a poison control center right away.
Directions
adults and children 12 years and over: if possible, clean the affected area with mild soap and warm water and rinse thoroughly. Dry by patting or blotting with toilet tissue or a soft cloth before applying. apply externally to the affected area up to 3 or 4 times daily. children under 12 years of age: ask a doctor.
Inactive ingredients
Lanolin, Light Mineral Oil, Purified Water, White Petrolatum
— FDA label of CVS Topical Analgesic Hemorrhoidal, Cvs Pharmacy, Inc, effective March 27, 2026. See the official label on DailyMed →
Gaayou Numbing · Jiangxi Yudexi Pharmaceutical Co., Ltd
Dibucaine hydrochloride 0.5%, cream (topical)
Active ingredient
Dibucaine hydrochloride 0.5%
Purpose
Local Anesthetic
Uses
For temporary relief of local discomfort, itching, pain, soreness, or burning associated with minor skin procedure.
Warnings
For external use only.
Do not use
In children less than 2 year of age on open skin wounds Do not exceed the recommended daily dosage unless directed by a doctor Ask Doctor If symptoms persist for more than 7 days or subside but occur again within 3 days, stop use and consult a physician. Stop use and sek meditcal attention if signs of an alergy occur,such as rednes,irtation,sweling, pain, or other severe symptoms.If symptoms do not subside completely within 7 days, seek medical help. When Using Avoid contact with eyes, lf this happens, rinse thoroughly with water. Stop Use If symptoms persist for more than 7 days or subside but occur again within 3 days, stop use and consult a physician. Stop use and sek meditcal attention if signs of an alergy occur,such as rednes,irtation,sweling, pain, or other severe symptoms.If symptoms do not subside completely within 7 days, seek medical help. Keep Oot Of Reach Of Children
Keep out of reach of children
Directions
Before applying the numbing cream,make sure to wash your hands thoroughly and put on disposable procedure gloves. Clean the area of the body receivina the procedure,Dry completely. Apply a generous amount of numbing cream to the cleaned area and rub it in thoroughly in a circlar motion for 30 to 60 seconds,Then. cover with plastic wrap. Leave the cream and wrap in place for 30 to 45 minutes,Wipe away the cream and thoroughly clean the area to prepare for the upcoming procedure.
Inactive ingredients
Purifed Water,Thymol,tween,Carbomeralcohol,azone.
— FDA label of Gaayou Numbing, Jiangxi Yudexi Pharmaceutical Co., Ltd, effective July 21, 2026. See the official label on DailyMed →
This page is not medical advice. Read the label on your package, and ask a pharmacist or doctor if you are not sure a medicine is right for you, for your child, or with your other medicines.
Same medicine, other brands
Each group lists the products that have exactly the same active ingredient, in the same amount and form, as registered with the FDA (NDC Directory). A store brand in the same group has the same medicine as the name brand; inactive ingredients, flavors and package sizes can differ. Each product links to its own official label.
Dibucaine 1% · ointment (topical) · 4 products
Dibucaine 0.28 g/28 g · ointment (topical) · 1 product
Drug Facts for this strength and form ↑
| Brand or product name | Company on the label | Label |
|---|---|---|
| Dibucaine | Akron Pharma Inc. | DailyMed |
Dibucaine 10 mg/mL · ointment (topical) · 1 product
Drug Facts for this strength and form ↑
| Brand or product name | Company on the label | Label |
|---|---|---|
| CVS Topical Analgesic Hemorrhoidal | Cvs Pharmacy, Inc | DailyMed |
Dibucaine hydrochloride 0.5% · cream (topical) · 1 product
Drug Facts for this strength and form ↑
| Brand or product name | Company on the label | Label |
|---|---|---|
| Gaayou Numbing | Jiangxi Yudexi Pharmaceutical Co., Ltd | DailyMed |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| dibucaine 1% ointment | Generic | $0.1419 per gram |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that sell this medicine
The company named on the package (maker or distributor), as listed in the FDA NDC Directory, with its number of over-the-counter products of this medicine.
- Cvs Pharmacy, Inc2 products
- Akron Pharma Inc.1 product
- Rugby Laboratories Inc.1 product
- Trifecta Pharmaceuticals USA LLC1 product
- Geri-Care Pharmaceuticals, Corp1 product
- Jiangxi Yudexi Pharmaceutical Co., Ltd1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific products or lots: check the name and lot number on your package.
-
February 17, 2023 · Class III · Terminated · D-0454-2023
Labeling: Incorrect or Missing Lot and/or Exp Date
DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1 — Akron Pharma, Inc.
-
March 15, 2021 · Class II · Terminated · D-0517-2021
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
DIBUCAINE TOPICAL ANESTHETIC 1% HEMORRHOIDAL OINTMENT 28GM ; NDC/UPC 0536-1211-95; OTC; OINTMENT — Cardinal Health Inc.
Sources
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- FDA rule for the Drug Facts label (21 CFR 201.66)
Only medicines marketed under FDA rules for nonprescription drugs (an FDA monograph or an FDA approval) are listed. Homeopathic products are not listed: the FDA does not evaluate them for safety or effectiveness.